Trump Reveals Deal to Lower Obesity Drug Costs
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Category : Search result: pharmaceutical licensing
Trump Obesity Drug Deal Boosts Pharma Stocks
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Essex Waives Taxi Licensing Fees Until 2025
The Town of Essex eliminates taxi licensing fees until December 2025, providing financial relief for drivers and improving transportation access for residents across the municipality.
Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board
Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
Ottawa's Solution to Doctor Shortage Crisis
Discover how Ottawa is implementing innovative solutions to tackle the critical physician shortage, from international recruitment to streamlined licensing processes that could become a national model.
Top FDA Drug Official Resigns Amid Federal Probe
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Ardena Appoints Chief Quality and Information Officers
Ardena strengthens its leadership with strategic hires of Chief Quality Officer and Chief Information Officer to drive operational excellence and digital transformation in pharmaceutical services.
Kimberly-Clark Buys Tylenol Maker in $48.7B Deal
In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.
Kimberly-Clark Buys Tylenol Maker Kenvue for $4.87B
In a landmark healthcare deal, Kimberly-Clark acquires Kenvue, the consumer health giant behind Tylenol, Band-Aid and Listerine, reshaping the North American healthcare landscape.
50+ Quebec Doctors Apply for New Brunswick Licences
New Brunswick sees surge of Quebec physician applications as healthcare recruitment efforts pay off. Discover why doctors are choosing to relocate and what this means for patient care.
Quebec doctors surge to Ontario after Ford's appeal
Ontario sees unprecedented surge in physician applications from Quebec after Premier Doug Ford's direct appeal, offering competitive incentives and streamlined licensing.
Blood Pressure Medication Recall Over Cancer Risk
Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.
BC Driver's Licence Changes: New Road Test Requirements
Major changes are coming to British Columbia's graduated licensing program. Learn how the new road test requirements and streamlined process will affect drivers across the province.
Eli Lilly's Weight Loss Drugs Spark Billion-Dollar Bidding War
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Weight-Loss Pill Race Revolutionizes Healthcare Market
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
Universal Music Signs First AI Licensing Deal
Universal Music Group breaks new ground by signing the music industry's first official AI music licensing agreement with SoundLabs, setting precedent for responsible AI integration in music creation.
Boehringer Ingelheim Licenses Novel Autoimmune Treatment
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.
Ex-Pharmacy Manager Guilty, Fined $5K for Multiple Violations
A former Melita pharmacy manager faces consequences after being convicted of multiple professional misconduct charges, including improper prescription practices and record-keeping failures.
Page 2 of 2